<?xml version="1.0" encoding="UTF-8"?>
<p>Yearly vaccination is the primary plan to control this infection; however, annual vaccination has limitations, including the time needed to design and produce the vaccine, high cost and inadequate protection due to antigenic shifts and drifts, dependence on egg-based production, regulatory approval procedures, limited worldwide availability, limited efficacy in elderly and unprimed populations, as well as lack of cross-reactivity by current vaccines [
 <xref rid="B14-biomolecules-11-00010" ref-type="bibr">14</xref>,
 <xref rid="B15-biomolecules-11-00010" ref-type="bibr">15</xref>].
</p>
